These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30439983)

  • 1. Influenza B viruses circulated during last 5 years in Mongolia.
    Tsedenbal N; Tsend-Ayush A; Badarch D; Jav S; Pagbajab N
    PLoS One; 2018; 13(11):e0206987. PubMed ID: 30439983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations at the monomer-monomer interface away from the active site of influenza B virus neuraminidase reduces susceptibility to neuraminidase inhibitor drugs.
    Fujisaki S; Imai M; Takashita E; Taniwaki T; Xu H; Kishida N; Yokoyama M; Sato H; Tashiro M; Odagiri T
    J Infect Chemother; 2013 Oct; 19(5):891-5. PubMed ID: 23529501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuraminidase inhibitor susceptibility and evolutionary analysis of human influenza B isolates from three Asian countries during 2012-2015.
    Hibino A; Massaad E; Kondo H; Saito R; Odagiri T; Takemae N; Tsunekuni R; Saito T; ; Kyaw Y; Lin N; Myint YY; Tin HH; Le Khanh Hang N; Mai LQ; Yagami R; Shobugawa Y; Lam T; Zaraket H
    Infect Genet Evol; 2018 Aug; 62():27-33. PubMed ID: 29665435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs.
    Fujisaki S; Takashita E; Yokoyama M; Taniwaki T; Xu H; Kishida N; Sato H; Tashiro M; Imai M; Odagiri T
    Biochem Biophys Res Commun; 2012 Dec; 429(1-2):51-6. PubMed ID: 23131559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza B viruses from different genetic backgrounds are variably impaired by neuraminidase inhibitor resistance-associated substitutions.
    Pascua PNQ; Marathe BM; Bisen S; Webby RJ; Govorkova EA
    Antiviral Res; 2020 Jan; 173():104669. PubMed ID: 31790712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes and Susceptibility to Neuraminidase Inhibitors in Individuals Infected With Different Influenza B Lineages: The Influenza Resistance Information Study.
    van der Vries E; Ip DK; Cowling BJ; Zhang JD; Tong X; Wojtowicz K; Schutten M; Boucher CA
    J Infect Dis; 2016 Jan; 213(2):183-90. PubMed ID: 26160744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
    Dapat C; Kondo H; Dapat IC; Baranovich T; Suzuki Y; Shobugawa Y; Saito K; Saito R; Suzuki H
    Antiviral Res; 2013 Sep; 99(3):261-9. PubMed ID: 23791870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Susceptibility of Influenza B Viruses to Neuraminidase Inhibitors Isolated during 2013-2014 Influenza Season in Mainland China].
    Huang W; Li X; Tan M; Wei H; Cheng Y; Guo J; Wang Z; Xiao N; Wang D; Shu Y
    Bing Du Xue Bao; 2015 Mar; 31(2):152-6. PubMed ID: 26164940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuraminidase inhibitor susceptibility testing of influenza type B viruses in China during 2010 and 2011 identifies viruses with reduced susceptibility to oseltamivir and zanamivir.
    Wang D; Sleeman K; Huang W; Nguyen HT; Levine M; Cheng Y; Li X; Tan M; Xing X; Xu X; Klimov AI; Gubareva LV; Shu Y
    Antiviral Res; 2013 Mar; 97(3):240-4. PubMed ID: 23267831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoring.
    Little K; Leang SK; Butler J; Baas C; Harrower B; Mosse J; Barr IG; Hurt AC
    Euro Surveill; 2015; 20(45):. PubMed ID: 26608955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza viruses with B/Yamagata- and B/Victoria-like neuraminidases are differentially affected by mutations that alter antiviral susceptibility.
    Farrukee R; Leang SK; Butler J; Lee RT; Maurer-Stroh S; Tilmanis D; Sullivan S; Mosse J; Barr IG; Hurt AC
    J Antimicrob Chemother; 2015 Jul; 70(7):2004-12. PubMed ID: 25786478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of human influenza A and B viruses in Myanmar from 2005 to 2007.
    Dapat C; Saito R; Kyaw Y; Naito M; Hasegawa G; Suzuki Y; Dapat IC; Zaraket H; Cho TM; Li D; Oguma T; Baranovich T; Suzuki H
    Intervirology; 2009; 52(6):310-20. PubMed ID: 19776616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The susceptibility of circulating human influenza viruses to tizoxanide, the active metabolite of nitazoxanide.
    Tilmanis D; van Baalen C; Oh DY; Rossignol JF; Hurt AC
    Antiviral Res; 2017 Nov; 147():142-148. PubMed ID: 28986103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors.
    Hatakeyama S; Sugaya N; Ito M; Yamazaki M; Ichikawa M; Kimura K; Kiso M; Shimizu H; Kawakami C; Koike K; Mitamura K; Kawaoka Y
    JAMA; 2007 Apr; 297(13):1435-42. PubMed ID: 17405969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium.
    Burnham AJ; Armstrong J; Lowen AC; Webster RG; Govorkova EA
    J Virol; 2015 Apr; 89(8):4575-87. PubMed ID: 25673705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance and molecular characterization of human influenza B viruses during 2006-2010 revealed co-circulation of Yamagata-like and Victoria-like strains in eastern India.
    Roy T; Agrawal AS; Mukherjee A; Mishra AC; Chadha MS; Kaur H; Chawla-Sarkar M
    Infect Genet Evol; 2011 Oct; 11(7):1595-601. PubMed ID: 21708292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-Resistant and Genetic Evolutionary Analysis of Influenza Virus from Patients During the 2013 and 2014 Influenza Season in Beijing.
    Li X; Liao H; Liu Y; Liu L; Wang F; Song H; Cheng J; Liu X; Xu D
    Microb Drug Resist; 2017 Mar; 23(2):253-260. PubMed ID: 27203354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of high-yield influenza B virus vaccine viruses.
    Ping J; Lopes TJ; Neumann G; Kawaoka Y
    Proc Natl Acad Sci U S A; 2016 Dec; 113(51):E8296-E8305. PubMed ID: 27930325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed influenza A and B infections complicate the detection of influenza viruses with altered sensitivities to neuraminidase inhibitors.
    Mohr PG; Geyer H; McKimm-Breschkin JL
    Antiviral Res; 2011 Jul; 91(1):20-2. PubMed ID: 21549758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oseltamivir-resistant influenza viruses isolated in South Korea from 2005 to 2010.
    Cho HG; Choi JH; Lee HK; Mun SK; Lee JB; Jho EH; Kang C; Lim YH
    Arch Virol; 2013 Nov; 158(11):2365-70. PubMed ID: 23690054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.